The Aroon Indicator for ANGO entered a downward trend on October 22, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 160 similar instances where the Aroon Indicator formed such a pattern. In 135 of the 160 cases the stock moved lower. This puts the odds of a downward move at 84%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANGO as a result. In 66 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
ANGO moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ANGO's RSI Oscillator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 60 cases where ANGO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for ANGO just turned positive on October 23, 2026. Looking at past instances where ANGO's MACD turned positive, the stock continued to rise in 40 of 46 cases over the following month. The odds of a continued upward trend are 87%.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANGO advanced for three days, in 197 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
ANGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.838) is normal, around the industry mean (4.964). P/E Ratio (-13.330) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.005) is also within normal values, averaging (56.876).
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. ANGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The 10-day moving average for MXCT crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +12.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where MXCT advanced for three days, in 198 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The 10-day RSI Indicator for MXCT moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 19 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MXCT as a result. In 75 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for MXCT turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 42 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
MXCT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
MXCT broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MXCT entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.819) is normal, around the industry mean (4.142). P/E Ratio (-3.706) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MXCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ANGO | MXCT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 93 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 96 | |
PRICE GROWTH RATING 1..100 | 57 | 39 | |
P/E GROWTH RATING 1..100 | 27 | 56 | |
SEASONALITY SCORE 1..100 | 35 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ANGO's Valuation (17) in the Medical Specialties industry is in the same range as MXCT (27) in the null industry. This means that ANGO’s stock grew similarly to MXCT’s over the last 12 months.
ANGO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MXCT (100) in the null industry. This means that ANGO’s stock grew similarly to MXCT’s over the last 12 months.
ANGO's SMR Rating (96) in the Medical Specialties industry is in the same range as MXCT (96) in the null industry. This means that ANGO’s stock grew similarly to MXCT’s over the last 12 months.
MXCT's Price Growth Rating (39) in the null industry is in the same range as ANGO (57) in the Medical Specialties industry. This means that MXCT’s stock grew similarly to ANGO’s over the last 12 months.
ANGO's P/E Growth Rating (27) in the Medical Specialties industry is in the same range as MXCT (56) in the null industry. This means that ANGO’s stock grew similarly to MXCT’s over the last 12 months.
| ANGO | MXCT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | 2 days ago 76% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 72% | 2 days ago 89% |
| MACD ODDS (%) | 2 days ago 87% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 77% |
| Advances ODDS (%) | 20 days ago 73% | 14 days ago 79% |
| Declines ODDS (%) | 6 days ago 73% | 6 days ago 88% |
| BollingerBands ODDS (%) | 7 days ago 76% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANGO’s FA Score shows that 2 FA rating(s) are green while MXCT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANGO’s TA Score shows that 5 TA indicator(s) are bullish while MXCT’s TA Score has 3 bullish TA indicator(s).
ANGO (@Pharmaceuticals: Other) experienced а +2.90% price change this week, while MXCT (@Medical/Nursing Services) price change was -22.60% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
ANGO is expected to report earnings on Jan 07, 2027.
MXCT is expected to report earnings on Mar 16, 2027.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.
| Ticker / NAME | Correlation To ANGO | 1D Price Change % | ||
|---|---|---|---|---|
| ANGO | 100% | -0.41% | ||
| STRRP - ANGO | 48% Loosely correlated | +0.89% | ||
| MXCT - ANGO | 36% Loosely correlated | -13.08% | ||
| ICUI - ANGO | 34% Loosely correlated | +1.82% | ||
| BLCO - ANGO | 33% Poorly correlated | +1.96% | ||
| A - ANGO | 31% Poorly correlated | -1.27% | ||
More | ||||
A.I.dvisor indicates that over the last year, MXCT has been loosely correlated with RVTY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MXCT jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To MXCT | 1D Price Change % | ||
|---|---|---|---|---|
| MXCT | 100% | -13.08% | ||
| RVTY - MXCT | 45% Loosely correlated | -1.01% | ||
| A - MXCT | 44% Loosely correlated | -1.27% | ||
| QGEN - MXCT | 42% Loosely correlated | -0.08% | ||
| IQV - MXCT | 41% Loosely correlated | -1.32% | ||
| ILMN - MXCT | 40% Loosely correlated | -2.66% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GLU | 19.06 | 0.07 | +0.37% |
| Gabelli Utility & Income Trust (The) | |||
| QCLR | 28.36 | N/A | N/A |
| Global X NASDAQ 100 Collar 95-110 ETF (QCLR) | |||
| MARU | 29.47 | -0.12 | -0.39% |
| AllianzIM U.S. Equity Buffer15 Uncapped Mar ETF (MARU) | |||
| MFDX | 40.72 | -0.20 | -0.50% |
| PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX) | |||
| RING | 75.78 | -4.28 | -5.35% |
| iShares MSCI Global Gold Miners ETF (RING) | |||